脊髓性肌萎缩症（SMA）和肌萎缩侧索硬化症（ALS）是运动神经元疾病。 运动神经元控制用于爬行、行走、头部和颈部控制以及吞咽等活动的随意肌； 遗憾的是，目前还没有已知的运动神经元疾病治疗方法。 SMA 是一种遗传性疾病，大约四分之一的人是携带者。 SMA 症状通常在出生后不久就会显现出来 ...

CIRM funds stem cell research to institutions throughout California. On the map below, click on any marker to learn more about our funding to that institution. You can explore the awards they’ve ...

CIRM funds clinical trials across a broad range of diseases and conditions that include rare and genetic disorders, treatment-resistant and refractory diseases, and many forms of cancer. Our ...

Welcome to the frequently asked questions (FAQs) page of the California Institute for Regenerative Medicine (CIRM). Here, you’ll find answers to the most common questions you may have on CIRM.

Foundation – Discovery Stage Research Projects Xiaojie Qiu Mapping and modeling endothelial cell fate decisions for pulmonary arterial hypertension $1,540,798 Foundation – Discovery Stage Research ...

At the California Institute for Regenerative Medicine (CIRM), we are committed to the continued funding of groundbreaking research in regenerative medicine. To reflect this commitment, we are ...

The Alpha Clinics Network is funded and supported by the California Institute for Regenerative Medicine (CIRM). The Network features nine world-class medical centers throughout California with a ...

Translational Candidate ASCENT - Advanced Superdonor Cellular Enteric Neuropathy Therapy, is a donor progenitor cell population that replaces the enteric nervous system. Area of Impact ASCENT would ...

Prop 14 also mandated additional programs to bring advancements in research to all Californians, including launching patient access programs like the Community Care Centers of Excellence, designed to ...

CIRM advances regenerative medicine in California through collaboration, innovation, and support for all stages of research. CIRM provides awardees and the broader research community with access to ...

Rosa Canet-Avilés, PhD, is the Chief Science Officer (CSO) at CIRM, where she oversees all programs and strategies across the Agency. In this role, Rosa ensures the cohesive alignment of CIRM’s ...

About CIRM At CIRM, we never forget that we were created by the people of California to accelerate stem cell treatments to patients with unmet medical needs, and act with a sense of urgency to succeed ...